@outsourcedpharma.bsky.socialBluesky
RNA therapeutics are advancing fast. The outsourcing ecosystem has to keep up.
Chief Editor Louis Garguilo looks at how CDMOs, academia, automation and new service models could reshape RNA development and manufacturing.
www.outsourcedpharma.com/doc/cdmos-co...
#RNA #CDMO #Biopharma
@womeninbio-rtp.bsky.socialInterested in joining WIB? A new member promo is being offered through Oct. 21 with a 15% discount on member fees - use code FallintoWIB26 to apply it. Register and join our community today! 😊
engage.womeninbio.org/Web/Shared_C...
#WomenInBio #WomenInSTEM #Networking #SciSky #Biotech #Biopharma
@newsen.bsky.socialAjinomoto Bio-Pharma Services Launches New Global Brand Identity to Highlight Specialization Strengths #Japan #Tokyo #Biopharma #global_brand #Ajinomoto_Bio-Pharma
@outsourcedpharma.bsky.socialYour CDMO can make the product. But can the market afford it?
@drjbug.bsky.social examines why affordability should shape formulation, packaging and outsourcing decisions long before launch.
www.outsourcedpharma.com/doc/your-cdm...
#CDMO #Biopharma #pharmamanufacturing
@scalanovahealth.bsky.social1. EDI 844/845 Integration
2. NPI & MMIT Feeds
3. ASC 606 & ERP Sync
Impact:
• 3-7% Revenue Recovered
• 40-60% Burn Rate Reduction
• <30-Day Deployment
• 100% IP/Entity BOT Transfer
#Biopharma #AgenticAI #FinOps #LifeSciences
@outsourcedpharma.bsky.socialJoin me tomorrow for a great, live discussion!
Complimentary registration, thanks to Douglas Pharmaceuticals:
event.on24.com/wcc/r/547759...
@newsen.bsky.socialBreaking the DMTA Linearity: Transforming Biopharma Workflows for Enhanced Collaboration #USA #Cambridge #Biopharma #Zifo #DMTA
@leeasplund.bsky.socialWelcome to Wednesday Words, where I will define one word used in biotechnology or biopharma each Wednesday morning!
If you want to learn more, check out: sbee.link/xanqf8tupy
@scalanovahealth.bsky.social1. Zero-PHI Wedge (<30-day deploy)
2. Autonomous EDI 844/845 validation
3. Real-time ASC 606 ERP sync
4. 90-day BOT transfer to client GCC
Impact: Recapture 2-5% revenue & 100% IP ownership.
@outsourcedpharma.bsky.socialPartnerships aren’t really tested when everything is going well. Maria Elena Bottazzi shares how working through difficult moments turned collaborations into transformational relationships. shorturl.at/IfoKu
#Biopharma #Vaccines #TechTransfer #PharmaOutsourcing
@newsen.bsky.socialExploring the Future of Biopharma: Insights from BioFuture 2026 in NYC #United_States #New_York #healthcare #Biopharma #BioFuture
@scalanovahealth.bsky.social1. Auto-reconcile 3PL chargebacks
2. Validate PBM rebate claims in real-time
3. Cut dispute resolution cycles by 80%
Stop GTN leakage and protect commercial margins.
@drtimos.bsky.social💉 Vaccines & Infectious Diseases 🦠
#LucidQuest equips BioPharma & investors with real-time insights to outpace the curve.
📩 [email protected] or http://dlvr.it/TVhW6F
#Vaccines #InfectiousDiseases #BioPharma #DueDiligence #LifeScienceStrategy
@newsen.bsky.socialZifo Introduces AI-Driven Framework to Enhance Biopharma Discovery and Intelligence #USA #Cambridge #Biopharma #Zifo #Semantic_Layer
@drtimos.bsky.social🧠 Competitive Insights for #BioPharma and #HealthTech 🚀
#LucidQuest arms #pharma & #biotech with real-time intel to outpace rivals from R&D to market.
📩 [email protected] or http://dlvr.it/TVgdHV
#CompetitiveIntelligence #Strategy #MarketAccess
@outsourcedpharma.bsky.social3 days → 13 hours.
That’s the kind of AI use case worth paying attention to!
Bikash Chatterjee shares how AI can dramatically speed a review process while keeping human expertise in the loop.
Watch our latest Outsourcing Advisor: shorturl.at/nbpSo
#AI #Biopharma #Outsourcing #PharmaManufacturing
@leeasplund.bsky.socialWelcome to Wednesday Words, where I will define one word used in biotechnology or biopharma each Wednesday morning!
If you want to learn more, check out: sbee.link/np9kxjmv3g
@aiinmeditech.bsky.socialAn AI CAR-T Intelligence Platform can help strategy teams bring clinical, pipeline, competitive, and market signals into a more structured view.
CAR-T Navigator is built to support decision-making across the evolving cell therapy landscape.
@newsen.bsky.socialVeeva Vault CRM Solidifies Market Dominance with New Biopharma Partnerships #USA #Biopharma #Pleasanton #Vault_CRM #Veeva_CRM
@newsen.bsky.socialVeeva Gains Leadership Position as Another Biopharma Giant Chooses Vault CRM #USA #Veeva_Systems #Biopharma #Pleasanton #Vault_CRM